e-learning
resources
Berlin 2008
Sunday, 05.10.2008
Control of breathing and respiratory disorders during sleep
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Obstructive pulmonary disorder is a potential risk factor of cardiovascular diseases in obstructive sleep apnea
S. Osanai, S. Nakao, T. Ogasa, E. Toyoshima, Y. Ohsaki, N. Hasebe (Asahikawa, Japan)
Source:
Annual Congress 2008 - Control of breathing and respiratory disorders during sleep
Session:
Control of breathing and respiratory disorders during sleep
Session type:
Thematic Poster Session
Number:
892
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Osanai, S. Nakao, T. Ogasa, E. Toyoshima, Y. Ohsaki, N. Hasebe (Asahikawa, Japan). Obstructive pulmonary disorder is a potential risk factor of cardiovascular diseases in obstructive sleep apnea. Eur Respir J 2008; 32: Suppl. 52, 892
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on acute decompensated pulmonary hypertension
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Obstructive sleep apnea syndrome and cardiovascular diseases risk in patients with COPD
Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA
Year: 2012
Cardiovascular risk factors and the metabolic syndrome in patients with obstructive sleep apnea
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008
Obstructive sleep apnea can cause pulmonary hypertension in the absence of lung disease
Source: Eur Respir J 2004; 24: Suppl. 48, 111s
Year: 2004
Is obstructive sleep apnea syndrome a risk factor for pulmonary thromboemboli?
Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects II
Year: 2011
Unrecognised obstructive sleep apnoea is common in severe peripheral arterial disease
Source: Eur Respir J 2013; 41: 616-620
Year: 2013
Obstructive sleep apnoea and related comorbidities in incident idiopathic pulmonary fibrosis
Source: Eur Respir J, 49 (6) 1601934; 10.1183/13993003.01934-2016
Year: 2017
Incidence of cardiovascular complications in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA)
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007
The prevalance of cardiovascular disorders in patients with obstructive sleep apnoea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 293s
Year: 2002
Autoantibody against NBL1 in obstructive sleep apnea patients with cardiovascular disease
Source: International Congress 2017 – New insights into the understanding of sleep and the consequences of sleep apnoea
Year: 2017
Obstructive sleep apnoea and COPD
Source: Eur Respir Mon 2013; 59: 135-143
Year: 2013
Prevalence of obstructive airway disease in patients with obstructive sleep apnea
Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA
Year: 2012
Correlations between cardiovascular diseases and diabetes in obstructive sleep apnoea (OSA)
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012
Investigation of various factors in obstructive sleep apnea syndrome patients
Source: Eur Respir J 2006; 28: Suppl. 50, 194s
Year: 2006
Obstructive sleep apnea and specific cardiovascular outcomes
Source: International Congress 2018 – Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care
Year: 2018
The impact of obstructive sleep apnea syndrome on cardiovascular system in children
Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain
Year: 2011
Chronic obstructive pulmonary disease in patients with obstructive sleep apnea
Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep
Year: 2009
Leukocytosis as a marker of chronic inflammation and early cardiovascular risk in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2007; 30: Suppl. 51, 593s
Year: 2007
Obstructive sleep apnea syndrome as factor of arrhythmic syndrome emergence and increase of cardiovascular risk in patients with COPD
Source: Annual Congress 2013 –The heart of the matter: sleep disordered breathing
Year: 2013
Cardiovascular and metabolic consequences of obstructive sleep apnoea
Source: Eur Respir J 2001; 18: Suppl. 33, 519s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept